CATX Perspective Therapeutics, Inc. - 8-K

Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 27, 2026, Perspective Therapeutics, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). Of the 114,017,755 shares of common stock outstanding and entitled to vote at the Annual Meeting, 97,882,462 shares (or 85.85%) were represented, either in person or by proxy, constituting a quorum.

The following is a summary of the matters voted on at the Annual Meeting and the final voting results.

Proposal 1 – The Election Proposal . The stockholders of the Company elected Lori A. Woods, Heidi Henson, Maya Martinez-Davis, Frank Morich, M.D., Ph.D., Johan (Thijs) Spoor and Robert Froman Williamson, III to the Company’s Board of Directors (the “Board”) to hold office until the Company’s 2027 Annual Meeting of Stockholders and until his or her successor has been elected and qualified. The votes were cast as follows:

Nominee

For

Withheld

Broker Non-Votes

Lori A. Woods

69,622,536

7,660,689

20,599,237

Heidi Henson

74,298,922

2,984,303

20,599,237

Maya Martinez-Davis

77,085,447

197,778

20,599,237

Frank Morich, M.D., Ph.D.

62,317,819

14,965,406

20,599,237

Johan (Thijs) Spoor

77,090,696

192,529

20,599,237

Robert Froman Williamson, III

67,908,625

9,374,600

20,599,237

Proposal 2 – The Auditor Ratification Proposal . The stockholders of the Company ratified the appointment of WithumSmith+Brown, PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The votes were cast as follows:

For

Against

Abstain

Broker Non-Votes

97,636,978

125,426

120,058

-

Proposal 3 – Advisory Vote on Frequency of Advisory Stockholder Votes on Executive Compensation . The stockholders of the Company voted, on a non-binding advisory basis, on how frequently future non-binding advisory votes on the compensation of the Company’s named executive officers should be held. The votes were cast as follows:

1 Year

2 Years

3 Years

Abstain

Broker Non-Votes

76,479,166

274,495

364,497

165,067

20,599,237

In light of these voting results and other factors considered by the Board, the Company intends to hold a non-binding, advisory stockholder vote on the compensation of the Company’s named executive officers on an annual basis until the next required vote on the frequency of advisory votes to approve named executive officer compensation, or until the Board otherwise determines a different frequency for such non-binding votes.